The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated

FASEB J. 1997 Nov;11(13):1169-76. doi: 10.1096/fasebj.11.13.9367352.

Abstract

In contrast to two-chain urokinase (uPA), a chemical conjugate between uPA and native saporin (a cytotoxic plant seed ribosome-inactivating protein) did not require plasminogen activator inhibitors to be internalized. To dissect this pathway, we constructed a chimera consisting of the amino-terminal fragment (ATF) of human urokinase fused to a saporin isoform (SAP-3). The chimeric ATF-SAP toxin was expressed in Escherichia coli, purified, and characterized for its ribosome-inactivating activity. Besides being a potent inhibitor of protein synthesis in cell-free assays, ATF-SAP was specifically cytotoxic toward cells expressing human uPAR. Competition experiments indicated that both the human uPAR and the LDL-related receptor protein are involved in mediating the cell killing ability of ATF-SAP. We conclude that neither plasminogen activator inhibitors nor the catalytic moiety of urokinase are necessary to initiate these internalization pathways. Thus, saporin may play a role similar to plasminogen activator inhibitors in its ability to trigger internalization of uPAR-bound ligands through endocytic receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cell Survival / drug effects
  • Cloning, Molecular
  • Escherichia coli
  • Humans
  • Immunotoxins / pharmacokinetics*
  • Immunotoxins / toxicity
  • N-Glycosyl Hydrolases*
  • Peptide Fragments / pharmacokinetics*
  • Peptide Fragments / toxicity
  • Plant Proteins / pharmacokinetics*
  • Plant Proteins / toxicity
  • Protein Synthesis Inhibitors / pharmacokinetics
  • Protein Synthesis Inhibitors / toxicity
  • Receptors, Cell Surface / biosynthesis
  • Receptors, Cell Surface / physiology
  • Receptors, Urokinase Plasminogen Activator
  • Recombinant Fusion Proteins*
  • Recombinant Proteins / pharmacokinetics
  • Ribosome Inactivating Proteins, Type 1
  • Ribosomes / drug effects
  • Saporins
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator / pharmacokinetics*

Substances

  • Immunotoxins
  • PLAUR protein, human
  • Peptide Fragments
  • Plant Proteins
  • Protein Synthesis Inhibitors
  • Receptors, Cell Surface
  • Receptors, Urokinase Plasminogen Activator
  • Recombinant Fusion Proteins
  • Recombinant Proteins
  • Ribosome Inactivating Proteins, Type 1
  • urokinase-ATF-SAP-3, recombinant
  • N-Glycosyl Hydrolases
  • Saporins
  • Urokinase-Type Plasminogen Activator